Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2, the protein structure prediction AI platform that “solved ...

But figuring out the shape of each protein was historically a very slow, labor-intensive process. That was the big breakthrough that DeepMind achieved with AlphaFold: it meshed machine learning ...

UK initiative to harness big biological data sets and look deeper into how the human body works and malfunctions ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

The company was founded by Dr Simon Kohl, previously a co-lead of DeepMind’s protein design team and a senior research scientist on DeepMind’s AlphaFold2, the project which earned a Nobel ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and ...

The UK-registered company will be able to tap into DeepMind's AI-powered AlphaFold engine that last year became the first to solve the tricky problem of predicting protein folding, but will ...